Status:
COMPLETED
Recovery From Paranoia: a Qualitative Exploration
Lead Sponsor:
University of Oxford
Conditions:
Paranoia
Persecutory Delusion
Eligibility:
All Genders
16+ years
Brief Summary
Paranoia, the experience of undue or excessive mistrust, exists on a continuum which includes suspicious thoughts, ideas of reference, and persecutory delusions. Persecutory delusions refers to strong...
Eligibility Criteria
Inclusion
- Participant has recovered from the paranoia. This is defined as: A.) conviction in persecution beliefs is rated as less than 10% and B.) not experiencing significant distress related to paranoia and C.) currently scoring outside the clinical range of the revised Green et al., Paranoid Thoughts Scale (R-GPTS; Freeman, 2019);
- Participants should have had experiences of paranoia in the context of non-affective psychosis. This will be determined by participant's agreement that they previously had the sort of thoughts listed in the revised Green et al. Paranoid Thoughts Scale (R-GPTS; Freeman, 2019);
- Participant is currently a patient of Oxford Health NHS Foundation Trust;
- Participant is willing and able to give informed consent for participation in the study;
- Aged 16 years or above;
- Participant has sufficient English language skills to participate in the interview.
Exclusion
- The following exclusion criteria will apply based on concerns regarding risk and capacity to consent:
- Currently experiencing acute psychiatric symptoms which preclude ability to participate in a sustained interview;
- Diagnosis of a moderate to severe intellectual disability;
- High levels of associated risk to self or to others e.g. actively suicidal;
- Primary diagnosis of alcohol or drug misuse; personality disorder; significant forensic history;
- At the time of recruitment COVID-19 restrictions do not permit face-to-face interviews and the participant is not willing or able to conduct the interview remotely via video call.
Key Trial Info
Start Date :
June 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 16 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04824781
Start Date
June 9 2021
End Date
February 16 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Health NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom, OX3 7JX